Multiple Sclerosis. The definite diagnosis of Multiple Sclerosis, and must be supported by all of the following: • Investigations which unequivocally confirm the diagnosis to be Multiple Sclerosis; and • Multiple neurological deficits which occurred over a continuous period of at least 6 months. Other causes of neurological damage such as SLE and HIV are excluded.
Multiple Sclerosis. Unequivocal diagnosis of Multiple Sclerosis attested by a neurologist. The illness must be evidenced by typical clinical symptoms of demyelination and impairment of motor and sensory functions, as well as by MRI results. In order to confirm the diagnosis, the Insured/Insured Person must display neurological anomalies that have endured for an ongoing period of at least six (6) months, or must have had at least two (2) clinically documented episodes with an interval of at least one (1) month in between, or at least one clinically documented episode together with characteristic findings in the cerebrospinal fluid, as well as specific brain injuries detected by the MRI.
Multiple Sclerosis. Diagnosis by a Consultant neurologist of neurological abnormalities. The insured must exhibit neurological abnormalities that have existed for a continuous period of at least 6 months or must have had at least two clinically documented episodes. This must be evidenced by the typical symptoms of demyelination and impairment of motor and sensory functions as well as by typical MRI findings subject to the survival of the Insured person for a minimum period of 30 days from the date of diagnosis for the first time during the policy period.
Multiple Sclerosis. A definite diagnosis of multiple sclerosis by a neurologist. The diagnosis must be supported by all of the following:
Multiple Sclerosis. A definite diagnosis by a Consultant Neurologist of multiple sclerosis which satisfies both the following criteria: There must be current impairment of motor or sensory function, which must have persisted for a continuous period of at least six months. The diagnosis must be confirmed by diagnostic techniques current at the time of claim.
Multiple Sclerosis. Dread Disease description The unequivocal diagnosis thereof by a Medical Practitioner (preferably by a neurologist). The disease has to be evidenced by typical clinical symptoms of demyelination and impairment of motor and sensory functions as well as by typical MRI findings. Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental and sometimes psychiatric problems. For proving the diagnosis, the member must: • either exhibit neurological abnormalities that have DREAD DISEASE CATEGORIES EXCLUSION existed for a continuous period of at least 6 (six) months; or • have had at least two clinically documented episodes at least 1 (one) month apart; or • have had at least 1 (one) clinically documented episode together with characteristic findings in the cerebrospinal fluid as well as specific cerebral MRI lesions. Annexe E.4
Multiple Sclerosis. Unequivocal diagnosis of multiple sclerosis by a consultant neurologist holding such an appointment at an approved hospital. The Covered Person must exhibit neurological abnormalities that have existed for a continuous period of at least six months or must have had at least two clinically documented episodes. This must be evidenced by the typical symptoms of demyelisation and impairment of motor and sensory functions. Customer means the corporate or business entity to whom the Business Credit Card facility has been provided by the Policyholder and who shall nominate the person to whom the primary Business Credit Card shall be issued.
Multiple Sclerosis. Multiple neurological deficit over a period of more than six months, as a result of demyelination in the brain and spinal cord. The diagnosis has to be unequivocal and made by a consultant neurologist, following more than one episode of well-defined neurological symptoms, involving any combination of deficit in the optic nerves, brain stem, spinal cord, coordination or sensory function.
Multiple Sclerosis. Unequivocal diagnosis of multiple sclerosis by a specialist acceptable to the Company (preferably by a neurologist). The disease has to be evidenced by typical clinical symptoms of demyelination and impairment of motor and sensory functions as well as by typical MRI findings. For proving the diagnosis the insured must either exhibit neurological abnormalities that have existed for a continuous period of at least six months or must have had at least two clinically documented episodes at least one month apart or must have had at least one clinically documented episode together with characteristic findings in the cerebrospinal fluid as well as specific cerebral MRI lesions.
Multiple Sclerosis. Unequivocal diagnosis of Multiple Sclerosis attested by a neurologist. The illness must be evidenced by typical clinical symptoms of demyelination and impairment of motor and sensory functions, as well as by MRI results. In order to confirm the diagnosis, the Insured/Insured Person must display neurological anomalies that have endured for an ongoing period of at least six (6) months, or must have had at least two (2) clinically documented episodes with an interval of at least one
